Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Open accessThe DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Abstract
Technical advances in generating and phenotyping cardiomyocytes from human pluripotent stem cells (hPSC-CMs) are now driving their wider acceptance as in vitro models to understand human heart disease and discover therapeutic targets that may lead to new compounds for clinical use. Current literature clearly shows that hPSC-CMs recapitulate many molecular, cellular, and functional aspects of human heart pathophysiology and their responses to cardioactive drugs. Here, we provide a comprehensive overview of hPSC-CMs models that have been described to date and highlight their most recent and remarkable contributions to research on cardiovascular diseases and disorders with cardiac traits. We conclude discussing immediate challenges, limitations, and emerging solutions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Optimal cardiogenic mesoderm induction for all human embryonic stem cell (hESC) and induced pluripotent stem cell (hiPSC) lines was found at 1–4 μM CHIR99021 concentrations, rather than the typical 10–12 µM range reported for monolayer methods14,21–27.”
From Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease (2021) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, Y., Babcock, S. A., Hu, N., Maris, J. R., Wang, H., & Ren, J. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-40 · Cited by 130
RetractedTakahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 1×
“This results in the integration of reprogramming genes into the genome and subsequent reactivation of the endogenous counterparts [11, 14].”
BackgroundInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926 · cited 2×
“They were derived from the inner cell mass of blastocyst-stage embryos in 1998 by Thomson [1].”
MethodInduced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 2×
“This results in the integration of reprogramming genes into the genome and subsequent reactivation of the endogenous counterparts [11, 14].”
BackgroundA New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Cardiac excitation–contraction coupling
Bers, D. M. (2002) · Nature · doi:10.1038/415198a · Cited by 4,744 · cited 5×
“Force of contraction Ca sparks and Ca waves Efficient Ca transient induction by Ca influx through L-type Ca channels (Ca-induced Ca-release) [52] Force of contraction: 10–50 mN/mm(2) (ventricular myocytes) [240]”
BackgroundInfluentialBrugada, P., & Brugada, J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90253-j · Cited by 3,331
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · cited 4×
“Interestingly, Wang and colleagues recapitulated the pathophysiology of BTHS cardiomyopathy by combining patient-derived hiPSCs with genome editing, modified RNAs, and ‘‘heart on a chip’’ technologies [137].”
MethodInfluentialA molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
Research works printed but not linked: 2
- Romano C Gemme G Pongiglione R Rare cardiac arrhythmias of the pediatric age. II. Syncopal attacks due to paroxysmal ventricular fibrillation La Clin Pediatr 1963 45 656 683 14158288
- van den Berg MP Wilde AA Viersma TJW Brouwer J Haaksma J van der Hout AH Stolte-Dijkstra I Bezzina TCR Van Langen IM Beaufort-Krol GC Cornel JH Crijns HJ Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome J Cardiovasc Electrophysiol 2003 12 1 7 11405394 · DOI
Cited by
Giacomelli, E., Meraviglia, V., Campostrini, G., Cochrane, A., Cao, X., van Helden, R. W. J., Krotenberg Garcia, A., Mircea, M., Kostidis, S., Davis, R. P., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.05.004 · Cited by 622
“Nevertheless, they can recapitulate phenotypical traits of many genetic cardiac disorders in vitro (Carvajal-Vergara et al., 2010; Caspi et al., 2013; Dell’Era et al., 2015; Dudek et al., 2013; Giacomelli et al., 2017c; Moretti et al., 2010; Te Riele et al., 2017; Siu et al., 2012; Wang et al., 2014) and to some exten…”
BackgroundSelf-citationLewis-Israeli, Y. R., Wasserman, A. H., Gabalski, M. A., Volmert, B. D., Ming, Y., Ball, K. A., Yang, W., Zou, J., Ni, G., Pajares, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25329-5 · Cited by 536
Advances in stem cell research and therapeutic development
De Luca, M., Aiuti, A., Cossu, G., Parmar, M., Pellegrini, G., & Robey, P. G. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0344-z · Cited by 239
Stem Cells in the Treatment of Disease
Blau, H. M., & Daley, G. Q. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1716145 · Cited by 228
3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications
Zuppinger, C. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00087 · Cited by 171
Metadata
- Authors
- Giacomelli, E., Mummery, C. L., & Bellin, M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Bellin, M.
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2017-06-01
- Volume
- 74
- Issue
- 20
- Pages
- 3711-3739
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC5597692
- OpenAlex
- W2620563284
- Cited by
- 60
- References
- 265
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 7 · 2021: 5 · 2020: 11 · 2019: 12 · 2018: 7 · 2017: 2
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Cellular and Molecular Life Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- University of Twente Research Information (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Padua Research Archive (University of Padova) (submittedVersion)
- University of Twente Research Information (submittedVersion, other-oa)
- Funders
- European Research Council (323182)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- human pluripotent stem cell-derived cardiomyocytes, in vitro disease model, cardiovascular disease, therapeutic target discovery, heart disease
- MeSH terms
- Calcium, Cell Differentiation, Heart Diseases, Humans, Mitochondria, Mutation, Sarcomeres, Myocytes, Cardiac, Pluripotent Stem Cells, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes. https://app.cochat.ai/papers/10.1007/s00018-017-2546-5
- The paper
- Giacomelli, E., Mummery, C. L., & Bellin, M. (2017). Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-017-2546-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.